Exlites Holdings International Inc. Announces LOI to Acquire Devon Orthopedic Implants LLC

Exlites Holdings International Inc. Announces LOI to Acquire Devon Orthopedic Implants LLC.  Press Release /06/25/2021

TAMPA, FL, June 25, 2021 (PR NEWSWIRE) --  Exlites Holdings International Inc. (OTC PINK: EXHI), a health care company focused on medical and consumer health products, today announced it has signed a letter of intent (LOI) to acquire a Devon Orthopedic Implants LLC.  (DOI)  owners of proprietary patented medical products.   The acquisition would see EXHI absorb DOI.

“As we emerge from COVID, we are excited and optimistic for this acquisition and for the future for EXHI.  We seek to expand our product breadth and distribution deeper into the medical field.  DOI gives us a solid base that we can combine and accelerate our objective - which is to be a dominate player serving the medical community with innovative products that improve patients lives.” Stated Mark Julian, President of EXHI.

“We are moving quickly to complete the acquisition agreement within the next 60 to 90 days, enabling us to launch some new products in expanded distribution in the third quarter of 2021. There are many synergies between our two companies, and we are looking forward to a successful mutual path moving forward.”

Additionally, EXHI has filed all necessary disclosures and paperwork with the OTC Markets and is awaiting final clearance to be current on the OTC Markets.  The filings include calendar years Jan 31, 2020 and Jan 31, 2021 and 1^st qtr April 30, 2021.

To learn more about EXHI please visit the Exlites Holdings International, Inc. website at www.exlitesholdings.us.

About Exlites Holdings International Inc. (www.exlitesholdings.us)

Exlites Holdings International Inc. (OTC PINK: EXHI)

EXHI is a publicly traded company listed on the OTC markets. The company’s objective is to expand its client base with both medical and consumer products, growing and expanding our current product offerings with additional distribution outlets. The company has experience in several facets manufacturing, marketing, distribution and relationships. Within the medical space the company has proprietary, patented and patent pending products which make us standout from the competition, utilizing distribution which the company is in the process of maximizing. The company manufactures, distributes and bills medical products. The company has extensive experience in mergers and acquisitions, innovation and creativity, joint ventures, consumer health care goods and growing and scaling companies for profits and divestiture.

Cautionary Language Concerning Forward-Looking Statements:

This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected by EXHI. The public filings, if any, of Exlites Holdings International Inc. (OTC Pink: EXHI) may be accessed at www.otcmarkets.com. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. EXHI cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, EXHI does not undertake, and EXHI specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

Contact:

Exlites Holdings International, Inc.

8403 Benjamin Rd, Ste 100

Tampa, FL 33634

813-321-9551

info@exlitesholdings.us

Investor Relations:

813-321-9551

info@exlitesholdings.us